FindTrial
Sign In

Second generation sequencing technology in the post-renal transplantation infectivity Clinical application research in diseases

Second generation sequencing technology in the post-renal transplantation infectivity Clinical application research in diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000035483
Enrollment
Unknown
Registered
2020-08-12
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney transplant

Interventions

Gold Standard:Bacterial culture or virus PCR detection
Index test:Second&#32
generation&#32
sequencing&#32
technology&#32
for&#32
the&#32
detection&#32
of&#32
microbial&#32
sequences

Sponsors

Renji Hospital affiliated to Shanghai Jiao Tong University Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 70 Years

Inclusion criteria

Inclusion criteria: (1) Any age; (2) A history of kidney transplantation; (3) Signs of infection; (4) Patients with no clear infection lesions but recurrent fever with unknown etiology.

Exclusion criteria

Exclusion criteria: Patients unable to cooperate with sampling

Design outcomes

Primary

MeasureTime frame
procalcitonin;C-reactive protein;creatinine;bacterial culture;virus detection;neutrophil;white blood cell count;—

Contacts

Public ContactLi Dawei

Renji Hospital affiliated to Shanghai Jiao Tong University Medical College

Lidawei3000@126.com+86 13621816843

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026